RNLXY Renalytix plc OTC · United States

Renalytix (RNLXY) news

Renalytix plc is a public biotech or pharmaceutical company listed on OTC under the ticker RNLXY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Renalytix news

We have not published a story on Renalytix yet. When there is news, it will appear here.

Renalytix annual financials

Line	FY ended Jun 30, 2024	FY ended Jun 30, 2023
Revenue	$2.3 million	$3.4 million
Research and development	$9.3 million	$14.3 million
Net income (loss)	-$33.5 million	-$45.6 million
Cash from operations	-$30.1 million	-$34.1 million
Cash and equivalents	$4.7 million	$24.7 million

Latest balance sheet, Sep 30, 2024 (10-Q): cash and equivalents $909,000.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Renalytix

What is the ticker symbol of Renalytix?

Renalytix plc trades under the ticker RNLXY on OTC.

Where is Renalytix listed?

Renalytix plc is listed on OTC.

Which country or territory is Renalytix listed under?

Our directory records Renalytix plc under United States.

Does aibio.space cover Renalytix?

aibio.space lists Renalytix plc among 2,820 public biotech companies and publishes its news here as stories appear.

What was Renalytix's revenue last year?

$2.3 million for the fiscal year ended Jun 30, 2024, as reported to the SEC.

Is Renalytix profitable?

Renalytix plc reported a net loss of $33.5 million for the fiscal year ended Jun 30, 2024, and used $30.1 million of cash in operations, per its annual report to the SEC.

How much does Renalytix spend on research and development?

$9.3 million in the fiscal year ended Jun 30, 2024, per its annual report.

How much cash does Renalytix have?

$909,000 in cash at Sep 30, 2024, per its 10-Q.

Investor discussion: Renalytix

Members talk about Renalytix (RNLXY). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:RNLXY on TradingView.

Listing details

Company: Renalytix plc
Ticker: RNLXY
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction